145 related articles for article (PubMed ID: 22714556)
1. Toward a bioengineered heparin: challenges and strategies for metabolic engineering of mammalian cells.
Baik JY; Wang CL; Yang B; Linhardt RJ; Sharfstein S
Bioengineered; 2012; 3(4):227-31. PubMed ID: 22714556
[TBL] [Abstract][Full Text] [Related]
2. Metabolic engineering of Chinese hamster ovary cells: towards a bioengineered heparin.
Baik JY; Gasimli L; Yang B; Datta P; Zhang F; Glass CA; Esko JD; Linhardt RJ; Sharfstein ST
Metab Eng; 2012 Mar; 14(2):81-90. PubMed ID: 22326251
[TBL] [Abstract][Full Text] [Related]
3. Bioengineered Chinese hamster ovary cells with Golgi-targeted 3-O-sulfotransferase-1 biosynthesize heparan sulfate with an antithrombin-binding site.
Datta P; Li G; Yang B; Zhao X; Baik JY; Gemmill TR; Sharfstein ST; Linhardt RJ
J Biol Chem; 2013 Dec; 288(52):37308-18. PubMed ID: 24247246
[TBL] [Abstract][Full Text] [Related]
4. Optimization of bioprocess conditions improves production of a CHO cell-derived, bioengineered heparin.
Baik JY; Dahodwala H; Oduah E; Talman L; Gemmill TR; Gasimli L; Datta P; Yang B; Li G; Zhang F; Li L; Linhardt RJ; Campbell AM; Gorfien SF; Sharfstein ST
Biotechnol J; 2015 Jul; 10(7):1067-81. PubMed ID: 26037948
[TBL] [Abstract][Full Text] [Related]
5. Antibody-based assay for N-deacetylase activity of heparan sulfate/heparin N-deacetylase/N-sulfotransferase (NDST): novel characteristics of NDST-1 and -2.
van den Born J; Pikas DS; Pisa BJ; Eriksson I; Kjellen L; Berden JH
Glycobiology; 2003 Jan; 13(1):1-10. PubMed ID: 12634318
[TBL] [Abstract][Full Text] [Related]
6. Modulation of heparan sulfate biosynthesis by sodium butyrate in recombinant CHO cells.
Datta P; Yang B; Linhardt RJ; Sharfstein ST
Cytotechnology; 2015 Mar; 67(2):223-35. PubMed ID: 24468831
[TBL] [Abstract][Full Text] [Related]
7. Molecular cloning and expression of a third member of the heparan sulfate/heparin GlcNAc N-deacetylase/ N-sulfotransferase family.
Aikawa J; Esko JD
J Biol Chem; 1999 Jan; 274(5):2690-5. PubMed ID: 9915799
[TBL] [Abstract][Full Text] [Related]
8. Bioengineering murine mastocytoma cells to produce anticoagulant heparin.
Gasimli L; Glass CA; Datta P; Yang B; Li G; Gemmill TR; Baik JY; Sharfstein ST; Esko JD; Linhardt RJ
Glycobiology; 2014 Mar; 24(3):272-80. PubMed ID: 24326668
[TBL] [Abstract][Full Text] [Related]
9. The biosynthesis of anticoagulant heparan sulfate by the heparan sulfate 3-O-sulfotransferase isoform 5.
Duncan MB; Chen J; Krise JP; Liu J
Biochim Biophys Acta; 2004 Mar; 1671(1-3):34-43. PubMed ID: 15026143
[TBL] [Abstract][Full Text] [Related]
10. Metabolic engineering of mammalian cells to produce heparan sulfates.
Thacker BE; Sharfstein ST
Emerg Top Life Sci; 2018 Oct; 2(3):443-452. PubMed ID: 33525792
[TBL] [Abstract][Full Text] [Related]
11. 6-O-sulfotransferase-1 represents a critical enzyme in the anticoagulant heparan sulfate biosynthetic pathway.
Zhang L; Beeler DL; Lawrence R; Lech M; Liu J; Davis JC; Shriver Z; Sasisekharan R; Rosenberg RD
J Biol Chem; 2001 Nov; 276(45):42311-21. PubMed ID: 11551899
[TBL] [Abstract][Full Text] [Related]
12. Enzymatically active N-deacetylase/N-sulfotransferase-2 is present in liver but does not contribute to heparan sulfate N-sulfation.
Ledin J; Ringvall M; Thuveson M; Eriksson I; Wilén M; Kusche-Gullberg M; Forsberg E; Kjellén L
J Biol Chem; 2006 Nov; 281(47):35727-34. PubMed ID: 16984905
[TBL] [Abstract][Full Text] [Related]
13. Role of Deacetylase Activity of N-Deacetylase/N-Sulfotransferase 1 in Forming N-Sulfated Domain in Heparan Sulfate.
Dou W; Xu Y; Pagadala V; Pedersen LC; Liu J
J Biol Chem; 2015 Aug; 290(33):20427-37. PubMed ID: 26109066
[TBL] [Abstract][Full Text] [Related]
14. Lowered expression of heparan sulfate/heparin biosynthesis enzyme N-deacetylase/n-sulfotransferase 1 results in increased sulfation of mast cell heparin.
Dagälv A; Holmborn K; Kjellén L; Abrink M
J Biol Chem; 2011 Dec; 286(52):44433-40. PubMed ID: 22049073
[TBL] [Abstract][Full Text] [Related]
15. Blockage of undesirable endocytosis of recombinant human growth/differentiation factor-5 in Chinese hamster ovary cell cultures requires heparin analogs with specific chain lengths.
Kim MG; Lee GM
Biotechnol J; 2021 Oct; 16(10):e2100227. PubMed ID: 34347378
[TBL] [Abstract][Full Text] [Related]
16. Recombinant Heparin-New Opportunities.
Glass CA
Front Med (Lausanne); 2018; 5():341. PubMed ID: 30564580
[TBL] [Abstract][Full Text] [Related]
17. The spacing of S-domains on HS glycosaminoglycans determines whether the chain is a substrate for intracellular heparanases.
Bame KJ; Venkatesan I; Stelling HD; Tumova S
Glycobiology; 2000 Jul; 10(7):715-26. PubMed ID: 10910975
[TBL] [Abstract][Full Text] [Related]
18. N- and 6-O-sulfated heparan sulfates mediate internalization of coxsackievirus B3 variant PD into CHO-K1 cells.
Zautner AE; Jahn B; Hammerschmidt E; Wutzler P; Schmidtke M
J Virol; 2006 Jul; 80(13):6629-36. PubMed ID: 16775350
[TBL] [Abstract][Full Text] [Related]
19. Expression of the mouse mastocytoma glucosaminyl N-deacetylase/ N-sulfotransferase in human kidney 293 cells results in increased N-sulfation of heparan sulfate.
Cheung WF; Eriksson I; Kusche-Gullberg M; Lindhal U; Kjellén L
Biochemistry; 1996 Apr; 35(16):5250-6. PubMed ID: 8611511
[TBL] [Abstract][Full Text] [Related]
20. The putative heparin-specific N-acetylglucosaminyl N-Deacetylase/N-sulfotransferase also occurs in non-heparin-producing cells.
Toma L; Berninsone P; Hirschberg CB
J Biol Chem; 1998 Aug; 273(35):22458-65. PubMed ID: 9712870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
